Conventional research and development models in the medical technology industry are being challenged by pricing pressures, increasing market competition and longer commercialization cycles demanding that companies innovate better and faster.
In order to improve the productivity of their R&D functions, medical device companies should develop more cost-effective and scalable approaches that leverage global resources and partnerships with external innovation partners that can provide capabilities, infrastructure, technology and market access.
Join us for this live 60-minute complimentary eBroadcast as Frost & Sullivan and HCL discuss:
Click here to register, listen in on the experiences of others, participate in a live Q&A, and walk away with actionable strategies. Don't miss out - register today!
Charlie WhelanDirector, Growth Consulting, Healthcare & LifesciencesFrost & Sullivan
Sujat Sukthankar, Ph.D., MBAVice President, Devices R&DEndo Pharmaceuticals
Partha MarellaDirectorHCL America
Click here for a copy of Frost & Sullivan's Custom White Paper titled
“Looking Beyond the Product: How Top Medical Technology Companies are Engineering Solutions, Not Just Devices, for Competitive Advantage”